|
2007, Volume 13 No. 2
ARTICLE 6
Evaluation of Ginger
(Zingiber officinale Roscoe) Bioactive Compounds in Increasing the Ratio of T-cell Surface Molecules of CD3+CD4+:CD3+CD8+ In-Vitro
Tejasari
Department of Agricultural Product Technology, University of Jember, Jl. Kalimantan No. 37, Jember 68121, Indonesia
ABSTRACT
The potential ability of ginger bioactive compounds in increasing the ratio of
T-cell surface molecules of CD3+CD4+:CD3+CD8+ was investigated using dual tagging FITC and PE of monoclonal antibody anti-human with its fluorescence
measured by flow cytometer. Oleoresin was extracted using sinkhole distillation technique. Its components namely, gingerol in fraction-1, shogaol
in fraction 2 and zingeron in fraction-3 were separated by column vacuum
chromatography method. The doses of oleoresin, gingerol, shogaol, and zingeron tested were 50, 100,150, 200, and 250 μg/ml. Lymphocytes (2x106
cell/ml) from human peripheral blood were isolated using ficoll density gradient
technique, and cultured in the presence of the compounds in RPMI-1640 medium and phytohemaglutinin (PHA) mitogen for 96 h under normal conditions.
Percentages of T-cell surface molecules (CD4+ and CD8+) were determined
using dual-tagging FITC and PE fluorescents labeled on monoclonal antibody anti human. The fluorescence-labeled bands on the T-cell surface
molecules were counted using flow cytometer. The experiment revealed that
oleoresin and its three fractions increased the percentage of CD3+CD4+. The
compound in fraction 3 of oleoresin at 200 μg/ml increased by the highest
percentage of CD3+CD4+ of 9%, but slightly decreased the percentage of CD3+CD8+. These ginger bioactive compounds increased the ratio of
CD3+CD4:CD3+CD8+ T-cells with the highest increment of 30% from effects
of 200 μg/ml fraction 3 of oleoresin. This in vitro finding revealed that ginger
bioactive compounds potentially increased cellular and humoral immune response. Further clinical studies are needed to confirm the benefits of these
ginger bioactive compounds as a potential functional food for testing on HIV
infected patients.
Full Article >>
|
|
 |
|
March 1995, Vol1 No.1
September 1995, Vol1 No.2
March 1996, Vol2 No.1
September 1996, Vol2 No.2
March 1997, Vol3 No.1
September 1997, Vol3 No.2
December 1998, Vol4 No.1&2
December 1999, Vol5 No.1&2
March 2000, Vol6 No.1
September 2000, Vol6 No.2
Mar/Sept 2001, Vol7 No.1&2
March 2002, Vol8, No.1
September 2002, Vol8, No.2
March 2003, Vol9 No.1
September 2003, Vol9 No.2
March 2004, Vol10 No.1
September 2004, Vol10 No. 2
2005, Vol 11 No.1
2005, Vo l11 No.2
2006, Vol 12 No.1
2006, Vol 12 No.2
2007, Vol 13 No.1
2007, Vol 13 No.2
March 2008, Vol 14 No.1
2008, Vol 14 No.2
2009, Vol 15 No.1
2009, Vol 15 No.2
2010, Vol 16(1)
2010, Vol 16(2)
2010, Vol 16(3)
2011, Vol 17(1)
2011, Vol 17(2)
2011, Vol 17(3)
|
|
|
|